Dietary Polyphenol Intake Inversely Associates with Fibrosis Scores in Individuals with MASLD
Nutrients · 2026
DOI: 10.3390/nu18203308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Caterina Bonfiglio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Data Science, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy. Hauptthemen laut MEDLINE: Polyphenols, Diet, Mediterranean, Liver Cirrhosis, Diet. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health.
Abstract (Originalsprache)
Background & aims. Plant-based dietary patterns, such as the Mediterranean diet, are considered protective against MASLD. The Mediterranean diet is rich in polyphenols (PP), plant-derived metabolites that exhibit anti-fibrotic effects in experimental models. This study aimed to evaluate the association between dietary polyphenol intake and fibrosis scores in patients with MASLD.
Methods
The study population comprised two retrospective cohorts, MICOL and NUTRIHEP, from southern Italy. Polyphenol intake was assessed using the EPIC food frequency questionnaire, and the food content of polyphenols was quantified using Phenol-Explorer. Liver fibrosis severity was assessed by MAF-5 and FIB-4.
Results
In a multivariable regression analysis adjusted for several potential confounders, comparing 381 patients with MAF-5 < 0 vs. 94 with MAF-5 > 1, consumption of total PP above the median (382.0–1356.8 mg/day) was associated with lower odds of high MAF-5 (OR 0.49; 95% CI 0.25–0.94; p = 0.031). Regarding PP subclasses, individuals with higher intakes of anthocyanins (15.00–252.00 mg/day) and stilbenes (0.04–0.55 mg/day) had lower odds of MAF-5 > 1 (OR 0.52; 95% CI 0.27–0.99; p = 0.045 and OR 0.49; 95% CI 0.27–0.92; p = 0.025, respectively). Considering PP sources, total flavonoid intake from fruit (≥60 mg/day) was associated with reduced high MAF-5 odds (OR 0.49; 95% CI: 0.24–0.99; p = 0.045), driven by fruit-derived anthocyanins (OR 0.52; 95% CI: 0.28–0.97; p = 0.04). A higher intake of PP from extra virgin olive oil was also associated with a 50% reduction in the odds of MAF-5 > 1 (OR 0.50; 95% CI: 0.26–0.96; p = 0.037).
Conclusions
In this exploratory study, a higher dietary polyphenol intake may protect against fibrosis in patients with MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Data Science, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
- Division of Gastroenterology, Ospedale di Taormina, Azienda Sanitaria Provinciale di Messina, 98123 Messina, Italy.
- Department BioMeTec, University of Catania, 95123 Catania, Italy.
- Scientific Direction, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
- Division of Gastroenterology, Ospedale di Acireale, Azienda Sanitaria Provinciale di Catania, 95124 Catania, Italy.
ORCID-Profile: Caterina Bonfiglio, Maria Noemy Pastore, Rossella Donghia, Fabio Galvano, Gianluigi Giannelli, Federico Salomone
Förderung
- Ministry of Health
Zitieren
APA
Bonfiglio, C., Pastore, M. N., Siani, M., Donghia, R., Musumeci, M., Galvano, F., Giannelli, G., & Salomone, F. (2026). Dietary Polyphenol Intake Inversely Associates with Fibrosis Scores in Individuals with MASLD. Nutrients. https://doi.org/10.3390/nu18203308
Vancouver
Bonfiglio C, Pastore MN, Siani M, Donghia R, Musumeci M, Galvano F, et al. Dietary Polyphenol Intake Inversely Associates with Fibrosis Scores in Individuals with MASLD. Nutrients. 2026. doi:10.3390/nu18203308
BibTeX
@article{Bonfiglio2026,
author = {Bonfiglio, Caterina and Pastore, Maria Noemy and Siani, Manuela and Donghia, Rossella and Musumeci, Martina and Galvano, Fabio and Giannelli, Gianluigi and Salomone, Federico},
title = {Dietary Polyphenol Intake Inversely Associates with Fibrosis Scores in Individuals with MASLD},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18203308}
}
EUVIMED